Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Biogen Inc.

Market Cap 29.02B 149B 25.3B 23.44B 21.94B 41.15B 2,738B 41.39B 278B 108B 1,348B 109B 107B 4,680B P/E 2026 *
31.7x
P/E 2027 * 16.5x
Enterprise Value 34.39B 177B 29.99B 27.77B 26B 48.76B 3,245B 49.06B 329B 128B 1,597B 129B 126B 5,547B EV / Sales 2026 *
3.42x
EV / Sales 2027 * 3.12x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day+0.11%
1 month+3.05%
3 months-0.31%
6 months+3.21%
Current year+0.67%
1 month 155.68
Extreme 155.68
163.36
Current year 147.5
Extreme 147.5
172.26
1 year 113.64
Extreme 113.64
172.26
3 years 110.07
Extreme 110.07
231.35
5 years 110.07
Extreme 110.07
322.71
10 years 110.07
Extreme 110.07
360
Manager TitleAgeSince
Chief Executive Officer 66 2022-11-13
Director of Finance/CFO 60 2025-02-28
Chief Tech/Sci/R&D Officer - 2020-12-31
Director TitleAgeSince
Director/Board Member 69 2010-03-22
Director/Board Member 77 2009-12-31
Director/Board Member 72 2019-06-18
Change 5-day change 1-year change 3-year change Capi.($)
+0.11%-.--% - - 29.02B
+0.33%-0.36%+19.66%-21.68% 62.05B
+0.20%-9.17%+58.54%+196.91% 54.52B
-3.92%+37.40%+37.40%+37.40% 41.55B
-1.63%+8.31%-52.53%-59.47% 39.06B
+3.50%+28.15%+146.95%-47.17% 25.38B
-0.78%-9.50%+43.47%+58.70% 19.62B
+1.74%-0.39%-1.99%+142.13% 16.89B
-0.05%+0.23%+61.48%+107.84% 15.89B
-1.66%-0.79%+58.81%+295.64% 12.98B
Average -0.23%+2.75%+41.31%+78.92% 31.99B
Weighted average by Cap. -0.36%+1.91%+35.43%+57.40%

Financials

2026 *2027 *
Net sales 10.05B 51.66B 8.76B 8.12B 7.6B 14.25B 949B 14.34B 96.3B 37.32B 467B 37.73B 36.92B 1,621B 10.38B 53.35B 9.05B 8.38B 7.85B 14.72B 980B 14.81B 99.45B 38.54B 482B 38.97B 38.13B 1,674B
Net income 1.18B 6.05B 1.03B 951M 890M 1.67B 111B 1.68B 11.28B 4.37B 54.67B 4.42B 4.32B 190B 1.97B 10.12B 1.72B 1.59B 1.49B 2.79B 186B 2.81B 18.86B 7.31B 91.43B 7.39B 7.23B 317B
Net Debt 5.37B 27.61B 4.68B 4.34B 4.06B 7.62B 507B 7.66B 51.46B 19.94B 250B 20.17B 19.73B 866B 3.35B 17.22B 2.92B 2.71B 2.53B 4.75B 316B 4.78B 32.09B 12.44B 156B 12.57B 12.3B 540B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
196.58USD
Average target price
220.25USD
Spread / Average Target
+12.04%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!